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We sought to investigate whether application of topical tetracycline has a limiting effect
on seroma formation in patients undergoing hernia repair using a polypropylene mesh.
This study was conducted in 96 patients undergoing an elective groin hernia repair.
Patients were randomized and divided into 2 groups. After the graft was placed, and
before external oblique muscle aponeurosis was closed, 5 mL tetracycline was
administered on the graft in the tetracycline group (tetra group, n ¼ 50), and 5 mL
isotonic saline was administered in the control group (n¼ 46) without putting in a drain.
Seroma checks via surface ultrasonography were done. Seroma amounts measured on the
first day were significantly higher in the tetra group (P¼ 0.04). There were no significant
differences regarding seroma measurements on the seventh day or in the first and second
months. Topical tetracycline application has no limiting effect on seroma formation after
a groin hernia operation.
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Hernia operations are among the most frequent-ly performed surgical operations. Graft use to
repair the defect is commonplace because graft use
decreases recurrence rate, and defect closure in large
abdominal hernias is easier with a mesh.1 The most
commonly used and least expensive mesh is the
polypropylene mesh. This mesh causes a foreign-
body reaction where it is placed, which leads to
seroma formation.2 Repeat aspirations of seromas
cause infection, and recurrence is seen on follow-up,
especially in large hernias.2 While drain use is not
recommended in groin hernias, drain use in other
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abdominal-wall hernias is left to the physician’s
discretion. The biggest problem with drain use is
transport of the infection by an ascending route.3
Tetracycline is an antibiotic, the solution form of
which is topically used for pleurodesis in chest
surgery.4 Some researchers also report successful
topical use of its solution in seroma treatment,
taking advantage of its sclerosing effect in cases
with breast carcinoma.5,6 Tetracycline has demon-
strated increased growth factor–like activity in
mesothelial cells exposed to tetracycline leading to
fibroblast proliferation.7 This study sought to inves-
tigate whether tetracycline has a reducing effect on
seroma development in cases undergoing elective
groin hernia repair using a polypropylene mesh.
Patients and Methods
The study was conducted according to the recom-
mendations of the Declaration of Helsinki on
Biomedical Research Involving Human Subjects.
This prospective, randomized, single-blind clinical
study was performed at the Baskent University,
Department of General Surgery, after obtaining
University Ethical Committee approval. All pa-
tients gave written, informed consent before the
operation.
This study was planned in patients undergoing
elective groin hernia repair between January 2011
and July 2012. The inclusion criteria were (1) being
in American Society of Anesthesiologists (ASA) 1
and 2 categories upon anesthesiologic examination
and (2) having a unilateral hernia. Exclusion
criteria were (1) a recurrent hernia; (2) incarcera-
tion or strangulation of hernia; (3) known hyper-
sensitivity to antibiotics and other drugs; (4)
known ascites, connective tissue disease, heart/
kidney failure, and hypoalbuminemia; and (5) use
of aspirin or other blood thinners or anticoagu-
lants.
A total of 147 patients were enrolled in the study.
The reasons for exclusion and the number of
excluded patients were as follows: 7 had an
incarcerated-strangulated hernia; 14 had a recur-
rent hernia; 2 had known allergies to antibiotics; 6
had bilateral hernias; and 16 had known heart/
kidney failure, were on aspirin or an anticoagulant,
were in an ASA 3 or higher anesthesia category, or
had a combination of these factors. Patients were
divided into tetracycline group and control group
using a computer-generated randomized sequence.
This randomization procedure was completed for
102 patients. Six patients did not continue as their
own controls or did not come for their ultrasonog-
raphy (USG) examinations on a regular basis. The
patients were blind to which group they were
assigned. As a result, 96 patients (tetra group, 50
subjects; control group, 46 subjects) came for USG
examinations on a regular basis and completed the
study (Fig. 1).
One hundred two patients underwent a Lichten-
stein-type grafted hernia repair using a polypropyl-
ene mesh (Prolene; Ethicon GmbH, Hamburg,
Germany). Before this study, we added isotonic
saline of varying amounts to the graft. During the
procedure, we observed that isotonic saline over 5
mL escaped via the external ring when the external
oblique aponeurosis was closed. Therefore, we
decided to add 5 mL fluid. After the graft was
placed and before the external oblique muscle
aponeurosis was closed, 5 mL tetracycline (100
mg) (tetracycline-oxytetracycline hydrochloride;
BIYOKAN, Ankara, Turkey) was administered onto
the graft in the tetracycline group and 5 mL isotonic
saline was administered onto the graft in the control
group. We applied the fluid by spraying it onto the
graft area with the help of an injector. Procedures of
routine operations of grafted hernia repair were
used, and no drain was placed. In all operations, an
inguinal incision was made parallel to the skin
crease, and a dissection was performed until the
external oblique muscle aponeurosis was accessed.
The external oblique muscle aponeurosis was
opened and dissected as far as the inguinal ligament
laterally and the anterior rectus sheath anteriorly.
The cord was suspended. In indirect hernias, the
hernia sac was dissected until the level of neck, and
a high ligation was done. In direct hernias, the
hernia sac was imbricated with continuous sutures.
A polypropylene mesh of adequate size for the
posterior wall (approximately 7 3 15 cm) was
prepared and placed in a way that its long axis
would be parallel to the cord. Attention was paid so
that the placed sheath would cover the whole area
between the anterior rectus sheath and inguinal
ligament, it would not impair cord circulation, and
one-third of its entire surface area would lie at the
side of the inguinal ligament and two-thirds at the
side of the anterior rectus sheath. For anchoring the
mesh, 2-0 polypropylene suture (Ethicon) was used.
The mesh was anchored to the inguinal ligament
laterally with continuous sutures, and to the anterior
rectus sheath medially with individual sutures.
Individual anchoring sutures were placed at the
line dissected for the cord’s passage. Then, the
external oblique muscle aponeurosis was closed
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with continuous 2-0 polyglactin 910 sutures (Vicryl;
Ethicon). All of these operations were performed by
the same surgeon (EK). Age, sex, body mass index,
type of anesthesia used, type of hernia, operative
time, and postsurgical complications were recorded
in all patients. During the postsurgical period,
radiologists (GC and EY), blinded to the patient
groups, searched for the presence and amount of
seroma with USG (13 MHz linear probe; Acuson
Antares Premium Edition Ultrasound System, Sie-
mens, Munich, Germany) on the first and seventh
days, and again in the first month as well as the
second and third months if a seroma was spotted at
first checks. Seroma measurement was done by
obtaining the length, width, and depth of the fluid
and multiplying the values, giving the volume of the
fluid in cubic millimeters. The units of these results
were converted to milliliters. Interobserver agree-
ments for continuous seroma measurements were
calculated by random marginal agreement coeffi-
cient.8 All agreement coefficients in control group
were higher than 0.60, and agreement coefficients
for tetra group were generally over 0.60, except for
the second month agreement coefficient, which was
lower because of the small sample size (n ¼ 2;
random marginal agreement coefficient ¼ 0.217). A
surgeon completed the processes of randomization
and recording of patient data on paper forms (ET).
Radiologists measuring seroma were blind to the
procedure, and only the operation group had the
information regarding whether the patient was
given tetracycline or isotonic saline during the
operation.
Statistical Analyses
The hypothesis was that using tetracycline on the
groin hernia repair with polypropylene mesh would
result in less seroma development during the
follow-up periods. For the calculation of sample
sizes, the mean difference and standard deviation of
seroma after repair using a polypropylene mesh
with tetracycline were accepted as 10 mL and 12
mL, respectively. A 2-sided 5% significance level
and 95% power were considered. Thirty-nine
participants in each group were calculated to be
required. Sample-size calculations were calculated
using Minitab Statistical Package Program (Release
14; Minitab, State College, PA). Statistical analyses
were performed with Statistical Package for the
Social Sciences software (Version 9.0; SPSS, Inc.,
Chicago, IL). The independent sample t test and
Mann-Whitney U test were used to compare the 2
groups in pairs for all possible combinations.
Numeric values were expressed as mean 6 SD.
Values for P , 0.05 were considered statistically
significant.
Results
All patients were operated on after receiving spinal
anesthesia, and no postsurgical early complications
Fig. 1 Randomization of the groups.
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developed in any patient. There were no statistically
significant differences between the 2 groups regard-
ing patient characteristics and general operative
outcomes (Table 1). Comparison of the number of
patients diagnosed with seroma in each group
revealed that the number of patients diagnosed
with seroma was significantly higher in the tetra
group on the first day (P¼ 0.02), whereas the groups
were similar on the seventh day and in the first and
second months (Table 1).
During the second month, seroma formation was
seen in 3 patients in the control group and 2 patients
in the tetra group. No seroma was seen in these
patients during the third month. The amount of
seroma on the first day in the tetra group was
significantly greater (P ¼ 0.04). There were no
significant differences regarding seroma measure-
ments at the seventh day or in the first and second
months (P ¼ 0.68, P ¼ 0.64, and P ¼ 0.74).
Discussion
The description of the Lichtenstein tension-free
mesh repair, about 23 years ago, opened a new era
in groin hernia repair.9 The method is simple,
effective, and is associated with low recurrence
rates (ranging from 0% to 0.7%).1 Owing to these
advantages, it is the preferred method for recon-
structing groin hernias for most surgeons world-
wide.
Several prosthetic meshes are available to the
surgeon. The ideal mesh properties include inert-
ness, resistance to infection, molecular permeability,
pliability, transparency, mechanical integrity, and
biocompatibility. Absorbable meshes do not remain
in the wound long enough for adequate collagen to
be deposited, while multifilament meshes can
harbor bacteria. Monofilament mesh is the most
popular today, with various types of polypropylene
having different advantages.10 Use of porous mesh
(polypropylene) allows a large surface area for in
growth of connective tissue, leading to permanent
fixation of the prosthesis in the abdominal wall.
Intraparietal placement of the prosthesis allows
well-vascularized tissue coverage of all aspects of
the prosthesis. Fears of complications related to
mesh implantation have proved unjustified. Pros-
thetic materials implanted in these spaces create
exaggerated seromas as a result of irritation and
following serum leakage.11 Especially in incisional
hernias, seroma and prolonged drainage are fre-
quently reported.12 When the mesh is used to repair
large and more complex incisional hernias, the risk
of seroma formation increases. Using the mesh
onlay technique, which requires more-extensive
dissection, is associated with an even greater
incidence of seroma formation.13 Previously report-
ed rates of seroma occurrence with different types of
mesh range from 4% to 8% with polypropylene
grafts (Prolene, Marlex) and 5% to 15% with
Table 1 Comparison of demographic, operational, and postsurgical ultrasonographic data of the patientsa
Group tetra (n ¼ 50) Group control (n ¼ 46) P value
Male/female 46/4 43/3 0.43
Age, y* 55.8 6 15.4 (25–74) 51.5 6 13.1 (22–74) 0.33
Body mass index, kg/m2* 33.8 6 4.7 (22.3–44.6) 35.1 6 4.1 (29.4–41.4) 0.32
Duration of operation, min* 56.2 6 12.4 53.5 6 15.4 0.43
Duration of hernia, mo* 21.9 6 22.1 (2–62) 18.8 6 19.2 (3–60) 0.68
Type of hernia
Direct 16 15 0.76
Indirect 24 23 0.69
Combined 10 8 0.42
USG on the first day
Seroma þ number of patients, % 27 (54%) 15 (32%) 0.02
Amount of seroma, mL* 15.6 6 4.4 10 6 3.8 0.04
USG on the seventh day
Seroma þ number of patients, % 30 (60%) 24 (52%) 0.21
Amount of seroma, mL* 82.5 6 19 109.6 6 26.7 0.68
USG at the first month
Seroma þ number of patients, % 10 (20%) 9 (19%) 0.91
Amount of seroma, mL* 20.8 6 6 12.4 6 4.1 0.64
USG at the second month
Seroma þ number of patients, % 2 (4%) 3 (6%) 0.27
Amount of seroma, mL* 0.07 6 0.02 0.05 6 0.02 0.74
aValues are mean 6 standard deviation.
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expanded polytetrafluoroethylene grafts (Gore-
Tex).14 In most instances, these seromas resolve
either spontaneously or with the insertion of drains
or serial percutaneous aspirations. However, indi-
cation for suction drainage differs among investiga-
tors.3
Topical sclerotherapy with tetracycline has long
been used successfully to treat malignant pleural
effusions to cause obliteration of the pleural space.4
Two reports suggest the effectiveness of tetracy-
cline, a topical sclerosing agent, in treating postop-
erative wound seromas in mastectomy patients.5,6
Topical tetracycline has been used to treat hydro-
cele testis,15 endometrial cysts,16 hepatic cysts,17
pericardial effusions,18 and the gallbladder lu-
men.19
We determined groin hernias as a prototype
during the planning phase. Our main aim was to
use tetracycline to decrease/prevent seroma from
developing in large abdominal wall hernias repaired
with polypropylene mesh. In abdominal hernia
repair, a potential tissue space naturally occurs
behind the dissected area created by the hernia
mass. Fluid collection in this pouch gives a surgeon
pause as to whether it is a complication or a natural
process of healing.11,12,20 The character of this
postoperative mass in the previous hernia region
cannot be discriminated with physical examination
alone. In our prospective study, USG was used to
detect and follow the nature of this fluid collection
in the hernia site. Resorption time was reported.
Post and associates21 performed Lichtenstein repair,
and presence of the seroma was checked by USG
and accepted as a fluid collection greater than 10
mL; these authors reported a seroma rate of 35% on
the second postoperative day, and 1.7% during the
sixth month. Another study reported the rate of
seroma as 5.8% on the seventh day and 7.8% during
the first month.22 In laparoscopic inguinal hernia
repairs, the duration of the seromas generally was
reported as 2 months, and 80% of them disappeared
by the end of the third month.11,23 One study by
Susmallian and associates12 demonstrated the pres-
ence of seroma in 100% of patients evaluated with
USG. The peak of seroma formation occurred 7 days
after the laparoscopic ventral hernia repair and
resolved almost completely by 90 days. Consistent
with the literature, the number of the patients with
seroma on the first and seventh days after surgery
was high in both groups. Beginning from the first
month, however, seroma was completely cleared
away by the third month. The reason more patients
were diagnosed with seroma in this study compared
with the literature was thought to be that we
detected the seroma not only on physical examina-
tion but also on USG, which is a more sensitive
radiologic technique. We also thought that the high
amount of seroma on the first day after the surgery
may be because both tetracycline and isotonic saline
were placed on the graft during the operation. Since
tetracycline absorption is slower than isotonic
saline, on the postoperative first day we found
statistically significant differences between the
groups.
In conclusion, we found no beneficial effect of
using topical tetracycline on seroma development in
grafted hernia repair. In addition, seroma develop-
ment should be expected, especially in the first week
after grafted hernia surgery, and it disappears by the
third month.
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